Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System
Carlsmed launched the aprevo Lumbar Bi-lateral Posterior System in the U.S., debuting it at the North American Spine Society's 41st Annual Meeting in San Antonio. The launch follows a limited market evaluation that began in February 2026, with the first-in-human procedure completed February 10, 2026.
Key figures
- Drug Name
- aprevo Lumbar Bi-lateral Posterior System
- First in human procedure
- February 10, 2026
- Limited market evaluation start
- February 2026
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.